Published in Curr Opin Pharmacol on August 01, 2004
IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest (2006) 2.41
Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol (2013) 2.11
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood (2009) 1.94
Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther (2007) 1.83
Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol (2005) 1.20
A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res (2011) 1.12
Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J Invest Dermatol (2008) 1.04
Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther (2010) 1.02
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy. Neurol Clin (2008) 1.01
Cessation of blood-to-brain influx of interleukin-15 during development of EAE. J Cereb Blood Flow Metab (2009) 1.00
IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol (2013) 0.99
Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J Leukoc Biol (2011) 0.96
Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis (2005) 0.96
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis Markers (2013) 0.91
Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin Exp Immunol (2006) 0.91
Serum cytokine and chemokine profiles in patients with myasthenia gravis. Clin Exp Immunol (2014) 0.90
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis? Arthritis Res Ther (2005) 0.87
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases. Arthritis Res Ther (2009) 0.86
Neonatal local noxious insult affects gene expression in the spinal dorsal horn of adult rats. Mol Pain (2005) 0.86
Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor. Psychoneuroendocrinology (2010) 0.86
Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J Gastroenterol (2009) 0.85
Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction. Br J Pharmacol (2006) 0.84
Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression. Front Immunol (2016) 0.83
Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study. Inflamm Res (2012) 0.82
Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A (2016) 0.81
Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases. Indian J Dermatol (2009) 0.81
Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis. PLoS One (2013) 0.78
Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin Immunopathol (2006) 0.78
Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling. Clin Immunol (2014) 0.76
Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res (2015) 0.75
The clinical significance and impact of interleukin 15 on keratinocyte cell growth and migration. Int J Mol Med (2016) 0.75
Exaggerated IL-15 and Altered Expression of foxp3+ Cell-Derived Cytokines Contribute to Enhanced Colitis in Nlrp3-/- Mice. Mediators Inflamm (2016) 0.75
miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice. Med Sci Monit (2015) 0.75
[Tissue retention of T cells as a therapeutic target in rheumatoid arthritis]. Z Rheumatol (2009) 0.75
[Psoriatic arthritis]. Wien Med Wochenschr (2006) 0.75
[Cytokines]. Z Rheumatol (2007) 0.75
The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. Arthritis Rheum (2012) 3.16
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum (2005) 2.37
A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol (2003) 2.37
A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol (2003) 1.62
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther (2006) 1.27
Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist. Arthritis Rheum (2007) 1.08
Chemoattraction of human T cells by IL-18. J Immunol (2003) 0.95
Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol (2004) 0.92
Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther (2004) 0.92
Expression and alternative processing of IL-18 in human neutrophils. Eur J Immunol (2006) 0.90
Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. AIDS (2005) 0.88
Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis. Curr Rheumatol Rep (2004) 0.86
Interferon gamma in keratinocytes in psoriasis. Eur J Dermatol (2003) 0.83
The anti-inflammatory potential of the filarial nematode secreted product, ES-62. Curr Top Med Chem (2004) 0.83
The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release. Ann Rheum Dis (2013) 0.82
Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis. Curr Pain Headache Rep (2005) 0.79
Prior elevation of IL-18 promotes rapid early IFN-gamma production during staphylococcal infection. Eur J Immunol (2005) 0.78
Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane. Ann Rheum Dis (2011) 0.78
The presence of IFN-alpha immunostained cells in the psoriatic epidermis. Eur J Dermatol (2003) 0.75